| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/09/2009 | WO2008082613A3 Factor ix moiety-polymer conjugates having a releasable linkage |
| 04/09/2009 | WO2008079464A3 Stable powder formulations of alum-adsorbed vaccines |
| 04/09/2009 | WO2008076333A3 Polymer-drug conjugates with tether groups for controlled drug delivery |
| 04/09/2009 | WO2008063511A3 Methods for treating pompe disease |
| 04/09/2009 | WO2006124538A3 Cosmetic composition for diminishing the appearance of lines and pores |
| 04/09/2009 | WO2005115457A3 Combined active and passive targeting of biologically active agents |
| 04/09/2009 | WO2005112587A3 Wound healing polymer compositions and methods for use thereof |
| 04/09/2009 | WO2005086775A3 Lumen-exposed molecules and methods for targeted delivery |
| 04/09/2009 | WO2005077071A3 Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| 04/09/2009 | WO2005041865A3 Compounds and method for treating cancer |
| 04/09/2009 | WO2005041684A3 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| 04/09/2009 | WO2005025513A3 Guanidinium derivatives for improved cellular transport |
| 04/09/2009 | US20090094715 Methods of use of antibodies with reduced immunogenicity or toxicity |
| 04/09/2009 | US20090093780 Intraocular iontophoretic device and associated methods |
| 04/09/2009 | US20090093617 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 04/09/2009 | US20090093552 Addition of lecithin as an antistatic agent for the crystallization processing of organic molecules |
| 04/09/2009 | US20090093551 Remotely triggered release from heatable surfaces |
| 04/09/2009 | US20090093550 Biocompatible foams, systems, and methods |
| 04/09/2009 | US20090093549 Aqueous Pharmaceutical Compositions Of 2,6-Diisopropylphenol (Propofol) And Their Uses |
| 04/09/2009 | US20090093522 Freeze-dried pantoprazole preparation and pantoprazole injection |
| 04/09/2009 | US20090093487 Compositions for topical application having androgenic actions |
| 04/09/2009 | US20090093414 methotrexate- alpha -PhePhe-NHC10H20O3NHCO O-hyaluronic acid; therapeutical agent; oseoarthritis (degenerative diseases ) |
| 04/09/2009 | US20090093411 Long-acting hormone and growth factor compositions and uses thereof |
| 04/09/2009 | US20090093400 Truncated keratinocyte growth factor (KGF) having increased biological activity |
| 04/09/2009 | US20090093014 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
| 04/09/2009 | US20090092739 Method of dip-coating dosage forms |
| 04/09/2009 | US20090092663 Tumor-targeted drug delivery systems and uses thereof |
| 04/09/2009 | US20090092659 containing protonated/acidified nucleic acids that are bactericidal; wound sealant, surgical drape , skin substitute |
| 04/09/2009 | US20090092658 Novel formulations of proton pump inhibitors and methods of using these formulations |
| 04/09/2009 | US20090092657 Amino acid combinant omega oil aphrodisiac |
| 04/09/2009 | US20090092633 Polyamino acid for use as adjuvant |
| 04/09/2009 | US20090092580 Dialkyl ether delivery agents |
| 04/09/2009 | US20090092557 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 04/09/2009 | US20090092552 Light stablized in vivo stain composition and method of manufacture |
| 04/09/2009 | US20090092548 Methods And Compounds For Targeting Tissues |
| 04/09/2009 | DE59303759C5 Wirkstoff-enthaltende festkörper mit einem gerüst aus hydrophilen makromolekülen und verfahren zu ihrer herstellung Drug-containing solid having a backbone of hydrophilic macromolecules and processes for their preparation |
| 04/09/2009 | DE4021517B4 Formulierungen mit verlangsamter Freisetzung wasserlöslicher Peptide Formulations with delayed release of water-soluble peptides |
| 04/09/2009 | CA2708316A1 Method for producing stable powder compositions |
| 04/09/2009 | CA2702028A1 Tripartite rnai constructs |
| 04/09/2009 | CA2701612A1 Neuromedin u derivative |
| 04/09/2009 | CA2701605A1 Granule, tablet and methods for producing the same |
| 04/09/2009 | CA2701291A1 Dendrimers for sustained release of compounds |
| 04/09/2009 | CA2701274A1 Lipopeptides for delivery of nucleic acids |
| 04/09/2009 | CA2701186A1 Oligofluorinated cross-linked polymers and uses thereof |
| 04/09/2009 | CA2700860A1 Human antibodies that bind mesothelin, and uses thereof |
| 04/09/2009 | CA2700828A1 Compositions comprising an antigen, an amphipathic compound and a hydrophobic carrier, and uses thereof |
| 04/09/2009 | CA2700410A1 Treatment of proliferative disorders using antibodies to psma |
| 04/08/2009 | EP2045270A2 Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives |
| 04/08/2009 | EP2045248A1 Method for preventing coloration of catechins and dentifrice composition |
| 04/08/2009 | EP2044959A1 In-situ gelling drug delivery system |
| 04/08/2009 | EP2044930A1 Composition for controlling lipase catalyzed reactions |
| 04/08/2009 | EP2044929A1 Oral fast distintegrating tablets |
| 04/08/2009 | EP2044150A2 Polymeric reagents comprising a terminal vinylic group and conjugates formed therefrom |
| 04/08/2009 | EP2044128A2 Novel amphiphilic cyclodextrin derivatives |
| 04/08/2009 | EP2043955A1 Metal oxide hydrogels and hydrosols, their preparation and use |
| 04/08/2009 | EP2043693A1 N-terminal polysialylation |
| 04/08/2009 | EP2043692A2 Polysaccharide derivatives of erythropoietin |
| 04/08/2009 | EP2043689A2 Drug delivery with stimulus responsive biopolymers |
| 04/08/2009 | EP2043670A1 Fermented plant extracts, methods of production and uses |
| 04/08/2009 | EP2043626A1 Composition comprising a retinoid and benzoyl peroxide |
| 04/08/2009 | EP2043616A1 N-terminal derivatisation of proteins with polysaccharides |
| 04/08/2009 | EP2043611A2 Metal-containing formulations and methods of use |
| 04/08/2009 | EP2043609A2 Pellet formulation comprising colloidal silicon dioxide |
| 04/08/2009 | EP2043608A1 Powders for reconstitution |
| 04/08/2009 | EP2043604A2 Topical compositions |
| 04/08/2009 | EP2043601A1 Aqueous gel formulation and method for inducing topical anesthesia |
| 04/08/2009 | EP2043590A1 Barrier film-forming germicidal compostition for controlling mastitis |
| 04/08/2009 | EP1753803B1 Polypeptides with the capacity to entrap drugs and release them in a controlled way |
| 04/08/2009 | EP1718667A4 Heterocyclic self-immolative linkers and conjugates |
| 04/08/2009 | EP1673065B1 Microemulsions of retinoids, and pharmaceutical compositions containing them |
| 04/08/2009 | EP1594499B1 Dosage forms containing a proton pump inhibitor, a nsaid, and a buffer |
| 04/08/2009 | EP1505076B1 Specific antibody fragments for the human carcinoembryonic antigen (cea) |
| 04/08/2009 | EP1499329B1 Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass |
| 04/08/2009 | EP1461015B1 Compositions containing both sedative and non-sedative antihistamines |
| 04/08/2009 | EP1409076A4 Method and apparatus for treating tumors using low strength electric fields |
| 04/08/2009 | EP1372729B1 Erodible polymers for injection |
| 04/08/2009 | EP1309355B9 Peptide and peptide mimetic conjugates with integrin-inhibitor properties |
| 04/08/2009 | EP1231905B1 Responsive polymeric hollow particles |
| 04/08/2009 | EP1007569B1 Stimulation of an immune response with antibodies labeled with the alpha-galactosyl epitope |
| 04/08/2009 | EP0961612B1 Protein stabilized pharmacologically active agents and their use |
| 04/08/2009 | EP0557512B2 Utilization in cosmetic or topical applications of an aqueous dispersion based on organopolysiloxanes and a crosslinked copolymer of acrylamide/neutralized 2-acrylamido 2-methylpropane sulfonic acid |
| 04/08/2009 | CN101405032A Anti-infective solution comprising a compound of pyrido(3,2,1-ij)-benzoxadiazine type |
| 04/08/2009 | CN101405031A Formulations for parenteral delivery of compounds and uses thereof |
| 04/08/2009 | CN101405004A Novel film-coated tablet |
| 04/08/2009 | CN101404996A Composition containing lignan compound |
| 04/08/2009 | CN101404995A Lignane compound-containing oil-in-water emulsion and composition comprising the same |
| 04/08/2009 | CN101404892A Microcrystalline cewllulose compositions |
| 04/08/2009 | CN101402738A Novel multipurpose cationic polymer |
| 04/08/2009 | CN101402736A Biodegradable unsaturated polyphosphate, preparation and use method thereof |
| 04/08/2009 | CN101402680A Shark liver regeneration factor, preparation method and medical uses thereof |
| 04/08/2009 | CN101401942A Azelnidipine composition |
| 04/08/2009 | CN101401941A Preparation and uses of tumor-targeted carrier material RGD-fatty alcohol series of compounds |
| 04/08/2009 | CN101401940A Albumin based polyacrylic acid nano-carrier and preparation method thereof |
| 04/08/2009 | CN101401928A Pain easing catablasm for bone regeneration and preparation method thereof |
| 04/08/2009 | CN101401922A Traditional Chinese medicine for preventing and controlling rhagadia and frostbite, and preparation method thereof |
| 04/08/2009 | CN101401878A Chinese medicinal composition for beauty treatment and face nursing, and preparation method thereof |
| 04/08/2009 | CN101401874A Lozenge for refreshing oneself and preparation method thereof |
| 04/08/2009 | CN101401849A Uses of tea polyphenol traditional Chinese medicine compound in preparing medicament for reducing blood fat and blood sugar |
| 04/08/2009 | CN101401814A Orally taken medicament formulation of clindamycin phosphate and preparing method thereof |
| 04/08/2009 | CN101401801A Curcumin glutin microsphere and preparation thereof |